Myocardial Infarction in Neonates: A Diagnostic and Therapeutic Challenge

Table 1

Demographic and perinatal data.

Case and year	Gestational age	Birth weight (g)	Age at diagnosis (days of life)	Clinical presentation	Ventricular function	Angiographic study	Etiology	Treatment	Mortality
7 (2002)	38	2820	14	Sepsis	Dysfunction and hypokinesia; Lateral basal and lateroapical	Unrealized	Myocarditis enterovirus	Diuretic; Immunoglobulins	No
2 (2007)	38	3190	1	Shock/arrythmia	Dysfunction and posterolateral hypochinesia	Normal	Fetal hypoxia	ACE inhibitor; Enoxaparin; ASA	No
3 (2010)	34	1720	8	Shock	Dysfunction and posterolateral hypochinesia	Unrealized	Myocarditis enterovirus (necropsy)	Immunoglobulins; Diuretic; Inotropic	Yes
4 (2011)	30	1700	1	Shock	Anterolateral hypochinesia	Normal	Umbilical venous channeling	ACE inhibitor; Enoxaparin; ASA	No
5 (2013)	40	3090	1	Heart murmur	Global myocardial hypertrophy; Aortic and pulmonary stenosis; Mitral prolapse	Coronary wall Hypertrophic Myocardial infarction in VI (necropsy)	Congenital heart disease	Diuretic	Yes
6 (2017)	39	3270	4	Respiratory distress and acrocyanosis	Moderate /severe; Dysfunction VI; Lateral/posterior and apical hypokinesia; Thrombus in left atrial appendage	Unrealized	Umbilical venous channeling	Diuretic; Inotropic; ACE inhibitor; Heparin; ASA	No